These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15775733

  • 1. The effect of hormone replacement therapy and simvastatin on plasma homocysteine.
    Sbarouni E, Kyriakides ZS, Kremastinos DT.
    J Womens Health (Larchmt); 2005 Mar; 14(2):154-8. PubMed ID: 15775733
    [Abstract] [Full Text] [Related]

  • 2. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M, Akan P, Dogan E, Karas C, Saygili U, Posaci C.
    Maturitas; 2006 Feb 20; 53(3):252-9. PubMed ID: 15990257
    [Abstract] [Full Text] [Related]

  • 3. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB, Donegà P, Zanca R, Barban A, Passaro A, Pansini F, Bonaccorsi G, Mollica G, Fellin R.
    Metabolism; 2002 Nov 20; 51(11):1463-70. PubMed ID: 12404199
    [Abstract] [Full Text] [Related]

  • 4. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E, Kyriakides ZS, Kremastinos DTh.
    J Am Coll Cardiol; 1998 Nov 20; 32(5):1244-50. PubMed ID: 9809932
    [Abstract] [Full Text] [Related]

  • 5. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A.
    Climacteric; 2005 Sep 20; 8(3):279-86. PubMed ID: 16390760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
    D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F.
    Acta Obstet Gynecol Scand; 2005 May 20; 84(5):474-7. PubMed ID: 15842212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun 20; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H, Ichikawa S, Takahashi T, Sakamoto H, Goto-Onozato K, Koya S, Kanda T, Nara M, Seki K, Murakami M, Kurabayashi M.
    Maturitas; 2006 Feb 20; 53(3):306-14. PubMed ID: 16040211
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.